INSPIRE_2B: INSPIRE, figure 2B

INSPIRE_2BR Documentation

INSPIRE, figure 2B

Description

Kaplan-Meier digitized data from INSPIRE, figure 2B (PMID 25701171). A reported sample size of 633 for a primary endpoint of OS in lung cancer.

Usage

INSPIRE_2B

Format

A data frame of 633 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (ct, necitumumab_ct)

Source

Paz-Ares L, Mezger J, Ciuleanu TE, et al. Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study. Lancet Oncol 2015; 16: 328–37.

Examples

summary(INSPIRE_2B)

kmplot(INSPIRE_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.